Article
Prediction of OncotypeDX recurrence score using H&E stained WSI images
2025-07-21
Abstract excerpt
The OncotypeDX 21-gene assay is a widely adopted tool for estimating recurrence risk and informing chemotherapy decisions in early-stage, hormone receptor-positive, HER2-negative breast cancer. Although informative, its high cost and long turnaround time limit accessibility and delay treatment in low- and middle-income countries, creating a need for alternative solutions. This study presents a deep learning-based...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6806bbb0-0402-548d-9eed-5e19668ff205
- DOI
- 10.1101/2025.07.21.25331907
